Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer | |
Xie, Yizhao; Li, Yi; Zhao, Yannan; Gong, Chengcheng; Hu, Xichun; Zhang, Jian; Wang, Leiping; Zhang, Sheng; Cao, Jun; Tao, Zhonghua | |
刊名 | SCIENTIFIC REPORTS |
2019 | |
卷号 | 9 |
ISSN号 | 2045-2322 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3595048 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Xie, Yizhao,Li, Yi,Zhao, Yannan,et al. Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer[J]. SCIENTIFIC REPORTS,2019,9. |
APA | Xie, Yizhao.,Li, Yi.,Zhao, Yannan.,Gong, Chengcheng.,Hu, Xichun.,...&Wang, Biyun.(2019).Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer.SCIENTIFIC REPORTS,9. |
MLA | Xie, Yizhao,et al."Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer".SCIENTIFIC REPORTS 9(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论